The GNRH1 Knockout SK-HEP-1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human liver adenocarcinoma cell line. This product introduces a targeted loss-of-function disruption in the GNRH1 gene, which encodes gonadotropin-releasing hormone 1. The resulting polyclonal pool contains a heterogeneous mix of edited alleles, enabling robust population-level analysis of GNRH1-dependent functions. It serves as a powerful in vitro system for dissecting the role of GnRH in both neuroendocrine and extrapituitary signaling contexts.
The parental SK-HEP-1 cell line is a well-characterized hepatic epithelial model originated from a liver adenocarcinoma. Although traditionally used in liver cancer research, SK-HEP-1 cells have been shown to express GnRH and its receptor, suggesting an autocrine/paracrine signaling loop that may influence tumor cell behavior. This cell line thus provides a relevant background to investigate the non-classical functions of GnRH outside the hypothalamic-pituitary-gonadal axis, particularly in cancer cell proliferation, migration, and survival.
GNRH1 encodes the gonadotropin-releasing hormone decapeptide that binds the GnRH receptor (GNRHR), a Gq/11-coupled GPCR. Ligand binding activates phospholipase C (PLC), generating IP3 and DAG, which trigger calcium release and protein kinase C (PKC) stimulation. These events propagate through the MAPK/ERK cascade to upregulate transcription of luteinizing hormone beta (LH??) and follicle-stimulating hormone beta (FSH??) subunits. The pathway is modulated by upstream kisspeptin (KISS1/KISS1R) signaling and feedback from sex steroids and glucocorticoids. In pituitary gonadotropes, this axis controls fertility, but in extrapituitary tissues, it can influence proliferation and apoptosis.
In the SK-HEP-1 context, disruption of GNRH1 eliminates autocrine GnRH production, enabling researchers to dissect its contribution to cancer cell autonomous signaling. Given that GnRH analogs are used therapeutically for hormone-dependent cancers, this knockout model allows direct interrogation of how loss of endogenous GnRH affects tumor cell phenotypes, including proliferation, invasiveness, and response to hormonal stimuli. The polyclonal format preserves genetic diversity while removing targeted gene function, making it suitable for pooled functional screens, dose-response studies, and comparative analyses against wild-type controls to identify GnRH-dependent molecular vulnerabilities in liver cancer.
Researchers can employ these cells in calcium flux and reporter gene assays to monitor GNRHR signaling, and use ELISA or RT-qPCR for LH/FSH quantitation and western blot for ERK phosphorylation. Applications span reproductive endocrinology, hormone-dependent cancers, and GPCR signal transduction. For further technical specifications and ordering details, please contact Ascent Research.
